Authors
Latest:
Semaglutide Carries Potential Risk of Worsening Diabetic RetinopathyDespite demonstrating numerous benefits, semaglutide has also been linked to an increased incidence of diabetic retinopathy, which was initially reported in the SUSTAIN-6 trial.
Latest:
Hepatitis Awareness Month: Help Your Patients Live(r) LongerMany of patients with hepatitis that pharmacists encounter have viral hepatitis, which can be easily remembered as the ABCs of hepatitis.
Latest:
HSV Offers Promising Target for Preventive, Therapeutic VaccinesVaccination provides an opportunity to prevent and treat herpes simplex virus infection.
Latest:
Understand the Inextricable Link Between the Pharmacy Revenue Cycle and 340BBy aligning the pharmacy revenue cycle with the 340B Drug Pricing Program, organizations can maximize revenue capture from medications while ensuring compliance with 340B requirements, leading to enhanced financial performance and improved care for underserved populations.
Latest:
Avoid Burnout During Times of UncertaintyOrganizations should focus on improving employee well-being and reducing workplace stressors.
Latest:
Humanizing Pharmacy: Shifting From Volume to Value for Improved Care and Reduced Pharmacist BurnoutRetail pharmacies benefit from the shift from a volume-centric model to a value-centric approach that focuses on enhancing patient care, reducing pharmacist burnout, and leveraging technology to improve efficiency and expand the scope of pharmacy services.
Latest:
Adverse Effects Impact Treatment Selection for VEGF-Targeted Oral TKIs in Metastatic RCCAxitinib, cabozantinib, and lenvatinib are first-line treatment options.
Latest:
Alternative Funding Programs Affect Our Most Vulnerable Patient PopulationsAFPs limit access to provider-prescribed specialty medications.
Latest:
Immune Checkpoint Inhibitors Change Treatment Landscape for Metastatic Cervical CancerApproval of a novel antibody-drug conjugate ushers in new second-line option.
Latest:
Can Smoking and Its Resulting Carbon Monoxide Exposure Improve Cancer Treatment Outcomes?Smoking increases exposure to carbon monoxide, and this may be associated with better clinical response to autophagy inhibitors.
Latest:
Understanding Pharmacy Deserts: How Can We Impact This Growing Trend?When a community loses a pharmacy, it loses a trusted health care provider. Understanding the root causes of these closures—and what we can do about it—can drive change.
Latest:
Navigating Data Integrity for Generic Drug ApprovalsContinuous innovation is required in various technological aspects to effectively manage the challenges of vast clinical data.
Latest:
Multiple Myeloma Pipeline Offers Promising New Options for TreatmentNovel therapeutics under investigation include CAR T-cell therapies, antibody-drug conjugates, and bispecific antibodies, as well as other unique drugs.
Latest:
Pharmacy Is Ready to Embrace Expanded RolesPandemic allows technicians to shine and be increasingly viewed as key to streamlining workflow.
Latest:
Emerging BCMA-Directed Therapies in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell TherapiesHere is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.
Latest:
Case Study: Insulin Sensitizers as Enhancers in Diabetes ManagementThe objective of this study is to evaluate the use of low-dose pioglitazone, without relying on high doses of insulin, by enhancing sensitivity as a suitable, cost-effective strategy compared to larger insulin doses in patients with limited access to care.
Latest:
Improving Medication Reconciliation Accuracy in a Primary Care PracticeAccurate medication reconciliations are critical for ensuring safe patient outcomes, and a correct medication list can help prevent drug-drug interactions, contraindications, and duplicate therapies.
Latest:
Pharmacists’ Sense of Meaning, Autonomy, and Pride Correlate With High Self-Evaluations of Pharmaceutical ServicesCommunity pharmacy leaders should focus on improving quality of work-life for their employees.
Latest:
Oncology Overview: Investigational Autologous TIL Immunotherapy LN-145 for Cervical CancerStudies suggest novel immunotherapy may have efficacy as monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
Latest:
Optimizing Delivery of Nimodipine in Patients With Subarachnoid HemorrhageThis article is sponsored by Azurity Pharmaceuticals, Inc.
Latest:
Modernizing Health Care With DigiceuticalsExplore the definition of digiceuticals, current digiceutical products available, and pharmacy implications.
Latest:
Accelerate Time to Specialty Pharmacy Therapy with Digital OptionsDigitizing hub processes can create an efficient and effective tech-driven patient access strategy speeding access to lifesaving therapies.
Latest:
Overcoming Failure as a Recent Pharmacy GraduateFailing is not final, and it does not define what kind of pharmacist or resident a student can be.
Latest:
Semaglutide Carries Potential Risk of Worsening Diabetic RetinopathyDespite demonstrating numerous benefits, semaglutide has also been linked to an increased incidence of diabetic retinopathy, which was initially reported in the SUSTAIN-6 trial.
Latest:
The Community Pharmacist’s Role in the Management of MigraineMigraine is a chronic neurological disease characterized by throbbing or pulsating unilateral or bilateral headache that can last from hours to days.
Latest:
2022-2023 Influenza Season Looks to Be SevereOutpatient treatment is primarily based on patient-specific factors, whereas oseltamivir remains the therapy of choice for inpatient settings.
Latest:
This Skin Cancer Awareness Month, Remind Patients of the Prevention BasicsAs summer approaches, remind patients to go back to basics with sunscreen and self-examinations.
Latest:
Partnership Between Public Health and Pharmacy: Opportunities to Increase Resource Sharing, Efficiency, and Improved Health OutcomesAdditional support is necessary to ensure that infrastructure development continues and that all pharmacists have the necessary tools to continue to provide immunization services.
Latest:
2022 ACC Consensus on Role of Nonstatin Therapies for LDL-Cholesterol LoweringSince the 2018 guideline’s publication, additional non-statin therapies such as bempedoic acid, evinacumab, and inclisiran, have been approved by the FDA for the management of hypercholesterolemia.
Latest:
Future Treatment Landscape of MZLClosing out their discussion on marginal zone lymphoma, the panel considers which future treatment strategies are most promising.
